SpadCare: digital home-care program for patients with PICC lines
Official title: Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
Run by Fundacion Miguel Servet · NCT06905119 · Data updated 2026-11-12
This program tests a smartphone app that teaches and remotely monitors adults with PICC lines who receive home infusions to help reduce catheter complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 201 (estimated) |
| Sponsor | Fundacion Miguel Servet Academic / other |
| Locations | 1 site (Pamplona, Navarre) |
| Status | Recruiting |
| Started | May 4, 2023 |
| Main results expected | April 1, 2025 |
| Study ends | July 31, 2026 |
| Registry record updated | September 12, 2025 |
| Trial ID | NCT06905119 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a PICC placed by the University Hospital of Navarra's Infusion and Vascular Access Team, planning at least one month of use, who own a smartphone, consent to the app, and allow access to their electronic medical record.
✕Probably not a fit
Patients without a smartphone or sufficient digital skills, those who refuse to install the app or to authorize medical-record access, or patients treated outside the enrolling center may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project uses a smartphone app (SpadCare) to deliver training and real-time support for adults with peripherally inserted central catheters (PICC) receiving home infusions or parenteral nutrition. Patients perform guided self-care and report symptoms through the app while the Infusion and Vascular Access Team monitors status remotely via telemedicine. The intervention aims to improve adherence to catheter-care procedures and enable earlier detection of catheter-related complications to reduce infections and unplanned healthcare visits. Enrollment is limited to consenting adults with a PICC placed by the University Hospital of Navarra and planned use of at least one month.
Why it matters
Potential benefit: If successful, the program could lower PICC-related infections and complications, reduce hospital visits, and improve patient confidence in managing home infusions.
How similar studies have gone: Prior telemedicine and mobile app interventions for catheter and home-infusion care have shown promising but variable reductions in complications and improved self-care in smaller studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>18 years. * Sign the informed consent form. * Have a Smartphone and accept the use of the APP. * Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month. Exclusion Criteria: * Patients with limitations in the use of digital resources or lack of Smartphone. * Patients who do not want to install the APP on their Smartphone * Patients who do not authorize access to their Computerized Medical Record (HCI).
Where it's running
-
Hospital Universitario de Navarra
Pamplona, Navarre, Spain Recruiting
Study contacts
- Study coordinator: María Inés Corcuera Martínez MI Corcuera Martínez, RN-PhD(c)
- Email: mi.corcuera.martinez@navarra.es
- Phone: +34 687609658
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
-
Education and a smartphone app to help organ transplant patients manage life, meds, and symptoms
A smartphone app plus teaching materials are tested to see if they improve quality of life and adherence to immunosuppressive therapy for adults who have had a liver or kidney transplant.
-
Integrated Chinese and Western medicine telehealth for long-term diabetes care
This project will test an online platform that combines Traditional Chinese Medicine and Western medicine to manage adults with type 2 diabetes remotely.
-
Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease
This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.